Health Biotech Showcases Global Compliance at CPHI Frankfurt 2025
Health Biotech Limited, a leading pharmaceutical company, successfully participated in the three-day CPHI Frankfurt 2025 main event held in Frankfurt, Germany, from October 28 to 30. The event provided a platform for the company to showcase its commitment to quality, innovation, and global compliance.
During the event, the managing director of Health Biotech, Mr. Parmjit Arora, spoke about the company's involvement. He highlighted Health Biotech's extensive portfolio of nearly 1,000 pharmaceutical products across major therapeutic categories. The company's booth attracted significant attention from overseas customers, reflecting its growing global presence.
Founded in 2005, Health Biotech has since expanded its manufacturing space to over 100,000 square feet. Its facility is certified by WHO-GMP, ISO 9001:2008, and complies with MHRA norms, ensuring high-quality standards. The company began its commercial operations in the same year and established a Government of India-approved R&D Centre in 2009, marking the beginning of its innovative journey.
Health Biotech's participation in CPHI Frankfurt 2025 underscored its dedication to global standards and its mission to build long-term international relations. With a robust product portfolio, state-of-the-art manufacturing facility, and a commitment to innovation, Health Biotech continues to make a significant impact in the global pharmaceutical industry.
